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Novel Determinants of Antibiotic Resistance: Identification of
Mutated Loci in Highly Methicillin-Resistant Subpopulations of
Methicillin-Resistant Staphylococcus aureus
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Medicine, University of Cambridge, Addenbrooke’s Hospital, Cambridge, United Kingdomd
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ABSTRACT We identified mutated genes in highly resistant subpopulations of methicillin-resistant Staphylococcus aureus
(MRSA) that are most likely responsible for the historic failure of the -lactam family of antibiotics as therapeutic agents against
these important pathogens. Such subpopulations are produced during growth of most clinical MRSA strains, including the four
historically early MRSA isolates studied here. Chromosomal DNAwas prepared from the highly resistant cells along with DNA
from the majority of cells (poorly resistant cells) followed by full genome sequencing. In the highly resistant cells, mutations
were identified in 3 intergenic sequences and 27 genes representing a wide range of functional categories. A common feature of
these mutations appears to be their capacity to induce high-level -lactam resistance and increased amounts of the resistance
protein PBP2A in the bacteria. The observations fit a recently described model in which the ultimate controlling factor of the
phenotypic expression of -lactam resistance inMRSA is a RelA-mediated stringent response.
IMPORTANCE It has been well established that the level of antibiotic resistance (i.e., minimum concentration of a -lactam antibi-
otic needed to inhibit growth) of a methicillin-resistant Staphylococcus aureus (MRSA) strain depends on the transcription and
translation of the resistance protein PBP2A. Here we describe mutated loci in an additional novel set of genetic determinants
that appear to be essential for the unusually high resistance levels typical of subpopulations of staphylococci that are produced
with unique low frequency in most MRSA clinical isolates. We propose that mutations in these determinants can trigger induc-
tion of the stringent stress response which was recently shown to cause increased transcription/translation of the resistance pro-
tein PBP2A in parallel with the increased level of resistance.
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It is generally agreed that the appearance of methicillin-resistantStaphylococcus aureus (MRSA) strains among clinical isolates
represents the single most serious blow to the chemotherapy of
S. aureus infections, since the unique resistance mechanism car-
ried by all MRSA strains provides protection against the single
largest family of antibacterial agents—the -lactam antibiotics
(1). Since their first appearance in clinical specimens in 1960, this
resistance mechanism has made its way into a large variety of
S. aureus lineages and diverse clones of MRSA have spread
throughout the globe to cause serious and often life-threatening
infections both in hospitals and in the community (2–5).
Most MRSA strains carry an identical—acquired— genetic de-
terminant mecA (6, 7) which is part of a mobile genetic element
(staphylococcal cassette chromosomemec element [SCCmec]) (8)
inserted into the S. aureus chromosome at a unique chromosomal
site. mecA encodes a protein, PBP2A, a peptidoglycan transpepti-
dase with extremely low affinity for the entire large family of
-lactam antibiotics (9), and the presence of this protein plays a
critical role in allowing MRSA strains to continue synthesis of
peptidoglycan and bacterial growth in the presence of high con-
centrations of-lactam antibiotics. A model for the mechanism of
action of PBP2A on the molecular level has been proposed (10).
In contrast to the common molecular mechanism of resis-
tance, individual MRSA clinical isolates differ widely in their sus-
ceptibility to -lactam antibiotics with individual MRSA strains
presenting methicillin MIC values as low as a few g/ml up to
several hundred g/ml depending on the particular MRSA clone,
and this variation in resistance level cannot be explained by tran-
scriptional regulation of mecA through the activity of regulatory
elements such as the mecl and mecR1 or blal and blaR1 genes (11,
12).
A detailed examination of the -lactam susceptibility of cul-
tures of MRSA strains presents an even more complex and intrigu-
ing picture. MRSA grown from single-cell inocula produce cul-
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tures that are highly heterogeneous with respect to their antibiotic
susceptibility with most cells (more than 99%) showing only
moderate- or low-level resistance often close to the MIC values of
methicillin-susceptible isolates. On the other hand, the same cul-
tures also contain bacteria with an extremely high level of resis-
tance—in the MIC range of several hundred g/ml—and the fre-
quency of such highly resistant cells in a given culture (104 to
105) appears to be specific for the particular MRSA clone. This
phenomenon has become known as the “heterogeneous” pheno-
type. It was first recognized and described in 1960, in the micro-
biological analysis of the historically first MRSA infection by
Jevons who was surprised to recover two MRSA populations with
widely different methicillin MIC values from a patient with an
MRSA infection (13). The methicillin MIC of the majority of the
bacteria was 2g/ml, but upon prolonged incubation of the spec-
imen, more bacteria were recovered with a much higher antibiotic
MIC value in the range of several hundred g/ml.
Most contemporary clinical isolates of MRSA express-lactam
resistance in a similar heterogeneous fashion (14). Plotting the
number of bacteria capable of forming colonies against the con-
centration of the antibiotic in the agar plates produce phenotypic
profiles called population analysis profiles (PAPs), and the shape
of the PAP is characteristic for the particular MRSA strain (15, 16).
The PAP was subsequently shown to be a unique phenotypic
marker of MRSA clones— highly reproducible in chronologically
distinct isolates of the same MRSA lineage (17). The presence of
highly methicillin-resistant cells in cultures of MRSA is of obvious
relevance both for the detection of MRSA in clinical specimens
and also for therapeutic options (18–20).
The stability of PAP for a given MRSA clone indicates that the
heterogeneous composition of MRSA cultures is genetically con-
trolled, i.e., the highly resistant subpopulations of bacteria must
carry mutations in some genetic determinants that are “wild type”
in the majority of less-resistant cells of the same clone.
Full genome sequences of a large number of MRSA strains are
now available in the National Center for Biotechnology Informa-
tion (http://www.ncbi.nlm.nih.gov). However, most of the se-
quenced strains show heterogeneous antibiotic resistance, and
therefore, the sequence information available relates only to the
genetic makeup of the “cell majorities” in each of these particular
MRSA clones and provide no information about unique mutated
genes that must be present in highly resistant subpopulations car-
ried by each one of the sequenced MRSA strains.
The purpose of this study was to identify mutated genes asso-
ciated with the rare highly resistant bacteria that are produced
with a low frequency (104 to 105) during growth of four histor-
ically early MRSA lineages belonging to the archaic clone of MRSA
(17). The four strains selected for the study carry the mecA deter-
minant on SCCmec type I cassettes that do not contain an active
form of the mecI or mecR regulatory genes (12). The -lactam
antibiotic (methicillin or oxacillin) MIC values for the majority of
bacteria in these four strains were in the range of 2 up to 12g/ml
of oxacillin. When these four “parental” MRSA strains were plated
on oxacillin-containing agar for PAPs, rare colonies (104 to
105) capable of growing on agar containing 100 g/ml of the
antibiotic were also detected. Cultures of such colonies—named
“H*R”—(for homogeneous and high-level resistance)—pro-
FIG 1 Heterogeneous expression of -lactam antibiotic resistance in four MRSA strains. (A to D) Population analysis profiles for strains UK13136 (A),
UK63/458 (B), E2125 (C), and E4278 (D) are shown by the lines with solid squares. H*R isolates capable of growing in the presence of 100 g/ml oxacillin were
picked from the agar plates as indicated by an asterisk. Population analysis profiles of cultures of H*R isolates are shown by the lines with empty squares.
Dordel et al.
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TABLE 1 Mutated loci in highly resistant (H*R) isolates identified in heteroresistant MRSA strains
Mutation
no.
Locus in S. aureus
COL Descriptiona
Nucleotide
changeb Amino acid change
Functional
categoryc
1 SACOL0314 Transcriptional regulator (rpiR family) C349448T Thr216Ile b
2 SACOL0403 Transcriptional antiterminator (bglG
family)
C409253 Del Frameshift after Ser461 b
3 SACOL0434 Hypothetical protein 1 C440981T Gln41Stop f
4 SACOL0460 IMP dehydrogenase (guaB) C463203T Arg310Cys a
5 SACOL0461 GMP synthase (guaA) A463937 Del Deletion after Ser27 a
C464191T Pro142Leu
6 SACOL0495 Hypothetical protein 2 G497663T Asp777Stop f
7 SACOL0533 Methionyl-tRNA synthetase (metS) G542898T Leu285Phe c
8 SACOL0544 Ribose-phosphate pyrophosphokinase
(prsA)
C552272T Pro291Leu a
9 SACOL0554 Hypoxanthine
phosphoribosyltransferase (hpt)
G562925A Met1Ile a
10 SACOL0555 Cell division protein (ftsH) C565004A Ala429Asp e
11 SACOL0562 Lysyl-tRNA synthetase (lysS) G570441T Arg11Leu c
G570684A Arg93His
12 SACOL0574 Glutamyl-tRNA synthetase (gltX) G597328A Glu439Lys c
13 SACOL0576 Cysteinyl-tRNA synthetase (cysS) C599284G His255Asp c
14 SACOL0583 Ribosomal protein L11 (rplK) A603893T Ile140Val c
15 SACOL0588 DNA-directed RNA polymerase, -
subunit (rpoB)
C608417T Ala477Val b
T610153A Tyr1056Asn
16 SACOL0589 DNA-directed RNA polymerase, =-
subunit (rpoC)
G611391A Arg239His b
G611672T Gly333Cys
C611927A Leu418Ile
A612110T Ile479Phe
T612157A Asp494Glu
C612859A Asn728Lys
C612921A Ala749Glu
C613500T Thr942Ile
G613517T Val948Leu
17 SACOL0758 1-Phosphofructokinase (fruK) G779646 Ins Frameshift after Ala35 d
18 Intergenic Hypothetical protein 3/glucose-6-
phosphate isomerase
C968358T f
19 SACOL0991 Oligopeptide ABC transporter,
permease (oppB)
G998492A Asp265Asn d
20 SACOL1689 GTP pyrophosphokinase (relA2) G1719144
Del
Frameshift after Met383 a
C1719536T Gln255Stop
21 SACOL1710 Valyl-tRNA synthetase (valS) A1741737T Asp177Val c
22 Intergenic Valyl-tRNA synthetase/DNA-3-
methyladenine glycosylase
C1742564
Del
f
23 SACOL1717 Porphobilinogen deaminase (hemC) C1747855T Thr265Ile d
24 SACOL1745 Ribosome binding site of pyruvate
kinase (pyk)
C1783697
Del
Deletion of RBS d
25 SACOL2038 tRNA N6-adenosine
threonylcarbamoyltransferase (gcp)
G2098447A Gly193Asp c
26 SACOL2072 DEAD box ATP-dependent RNA
helicase (srmB)
G2137588A Gly459Asp b
27 SACOL2108 Translation factor SUA5 (sua-5) C2168647G Pro104Arg c
28 SACOL2117 Fructose-bisphosphate aldolase (fbaA) T2177986
Del
Frameshift after Lys167 d
G2178061A Gly143Arg
C2178241T His83Tyr
29 SACOL2215 Ribosomal protein S13/S18 (rpsM) G2295683C Ile308Leu c
30 Intergenic Hypothetical protein 4/
hydroxymethylglutaryl-CoA
reductase
G2617978A f
a CoA, coenzyme A.
b C349448T, C at position 349448 changed to T; C409253 Del, deletion of the C at position 409253; G779646 Ins, insertion of G at position 779646.
c Functional categories a through g as defined in Table 2.
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duced highly and homogeneously resistant populations of bacte-
ria with MIC values in the range of several hundred g/ml.
Chromosomal DNA was prepared from the H*R cultures
along with DNA prepared from the corresponding heteroresistant
“parental” (majority) cells followed by full genome sequencing.
Mutated genes unique to the particular H*R culture were identi-
fied by comparison to the status of the same gene in the “parental”
culture.
Mutations in 27 genes and 3 intergenic sequences were identi-
fied in the highly resistant H*R derivatives recovered from the
four heteroresistant “families” of MRSA. While the mutated genes
represent a range of functional categories, we suggest that a com-
mon feature of these mutations may be their capacity to induce a
stringent stress response in the bacteria. This proposal is consis-
tent with recent evidence that identified a key role of the relA gene
complex in defining the level of -lactam resistance in laboratory
models of MRSA strains (20, 21). As experimental evidence
strongly suggested this, each of the four heteroresistant “parental”
MRSA strains described in the present communication could be
made to change their mode of expression of resistance from het-
erogeneous to homogeneous by the use of mupirocin, i.e., by ex-
perimentally inducing the stringent stress response in the bacteria
(22–30).
RESULTS
The majority of clinical MRSA isolates express-lactam resistance
in a heterogeneous fashion. As a first attempt to better understand
the genetic basis of this phenomenon, we selected four genetically
closely related and historically early MRSA strains which had very
similar heteroresistant phenotypes, as indicated by the virtually
superimposable population analysis profiles (PAPs) (Fig. 1). The
four strains included UK13136, the historically first MRSA, iso-
lated in 1960 in the United Kingdom (13) named in our study as
the “parental” strain of family A. This strain has already been
characterized by molecular techniques (31). The second MRSA
strain, ST63/458, was also isolated in the United Kingdom in 1963
and was the “parental” strain of family B in our study. Both of
these strains are of sequence type ST250 and carry an SCCmec type
I. The two additional parental strains, E2125 (parental strain of
family C) and strain E4278 (parental strain of family D), were both
isolated in Denmark in 1964 and 1967, respectively, and both were
ST247 carrying SCCmec type I. All four strains belonged to the
“archaic” clone of MRSA (17).
Figure 1 shows the rather similar PAPs of the four “parental”
MRSA strains; in each strain, the majority of bacteria had rela-
tively low oxacillin MIC values between 2 and 12g/ml. However,
each culture also contained—with a low frequency of about
105— highly resistant (mutant) subpopulations of bacteria with
an oxacillin MIC of400 g/ml.
Overnight cultures of the four parental strains were grown in
tryptic soy broth (TSB), and 1-ml portions of the turbid overnight
cultures were used to prepare the “parental” DNAs for sequenc-
ing. Aliquots of the rest of the overnight parental cultures were
plated for population analysis, and 20 of the rare highly resistant
colonies (named “H*R”) that appeared on the agar plates supple-
mented with 100 g/ml oxacillin (see the asterisks in Fig. 1), were
picked from the progeny of each of the four parental cultures. The
H*R colonies were resuspended in TSB and restreaked on tryptic
soy agar (TSA), and cultures of the 10 H*R colonies were grown in
TSB, retested for oxacillin resistance by PAP, and used to prepare
DNA for sequencing. Eventually, the DNA sequence of each H*R
colony was compared to the sequence of the corresponding “pa-
rental” culture in order to identify the genes that were mutated in
the H*R cultures.
On the basis of this comparison, mutations in 3 intergenic
sequences and 27 genes were identified in the stably resistant H*R
colonies recovered from the four heteroresistant MRSA strains
(Table 1).
The mutated genes, their putative functions, and the nature of
the nucleotide and amino acid change are listed in Table 1. The
following six genes carried multiple mutations: fbaA (3 muta-
tions), guaA (2 mutations), lysS (2 mutations), rpoB (2 muta-
tions), rpoC (9 mutations), and relA2 (2 mutations).
These genes may be involved in (p)ppGpp-mediated stringent
stress response: guaA, lysS, and relA2 are directly linked to the
synthesis of (p)ppGpp which targets RNA polymerase, the prod-
uct of rpoB and rpoC (32). The fbaA gene encoding fructose bis-
phosphate aldolase was reported to be downregulated in
(p)ppGpp-mediated stringent stress response induced by serine
hydroxamate (33). Of the 30 genetic loci carrying mutations, 27
are expected to alter function either by point mutations or by
frameshifts. The remaining 3 determinants were in intergenic se-
quences with a change in a single nucleotide. Thus, mutations in
27 different genes would appear to be responsible for the increase
in the resistance of H*R isolates to oxacillin either singly or
through a concerted effect of all mutations.
TABLE 2 Functional categories of mutations associated with highly resistant (H*R) isolates
Functional category
No. of
determinants
Mutation(s)a associated with H*R isolates in the following strain:
UK13136 (family A) ST63/458 (family B) E2125 (family C) E4278 (family D)
Guanine metabolism (category a) 5 guaA, guaB guaA, relA2, prsA relA2, hpt
Transcription (category b) 5 bglG, rpoB, RNA
helicase
rpoC rpiR, rpoB, rpoC
Translation/ribosomal structure (category c) 9 rpsM, lysS rplK gcp, cysS, valS lysS, gltX,metS,
sua-5
Transport/metabolism (category d) 5 pyk, hemC fbaA oppB, fruK
Cell division (category e) 1 ftsH
Unknown function (category f) 5 HP2, Intergenic Intergenic HP1, Intergenic
Total 30
a Genes potentially involved with induction of a stringent stress response are indicated in boldface print. The fbaA and oppB genes are downregulated by (p)ppGpp-mediated
stringent stress response (33). HP stands for hypothetical protein.
Dordel et al.
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Table 2 lists functional categories of the mutated genes identi-
fied in H*R isolates of the four MRSA families identified by capital
letters A through D. Of the 27 mutated genes, 21 were in guanine
metabolism (a), in transcription (b), in translation/ribosomal
structure (c) and/or in transport (d). Interestingly, in most H*R
isolates, mutation in a single gene was sufficient to produce the
highly resistant phenotype (Table 3). Thirteen out of 17 genes
listed in Table 3 are included in 3 functional categories: four
(guaA, prsA, hpt, and relA2) in guanine metabolism; two (rpoB
and rpoC) in transcription; and seven (metS, lysS, cysS, valS, gcp,
sua-5, and rpsM) in translation/ribosome structure. Each of these
mutations would be expected to trigger the stringent stress re-
sponse and produce high and homogeneous resistance.
Twelve H*R isolates each carrying a single mutation (Ta-
ble 3) were compared to their respective parental strains for the
relative amounts of PBP2A. Cells were grown in the presence of
0.5 g/ml oxacillin to induce the mecA gene, and membrane
fractions were prepared for Western blotting. All H*R isolates
showed at least 2-fold increase in PBP2A compared to their
parental strains (Fig. 2) suggesting that each mutation resulted
in the recruitment of increased amounts of PBP2A into the cell
membranes.
TABLE 3 H*R isolates carrying mutations in a single gene
Mutation no.a Locus in S. aureus COL Gene H*R strain Functional category
5 SACOL0461 guaA A3, BB9 a
7 SACOL0533 metS DD8 c
8 SACOL0544 prsA B5 a
9 SACOL0554 hpt DD3 a
11 SACOL0562 lysS AA9 c
13 SACOL0576 cysS CC3 c
15 SACOL0588 rpoB DD9 b
16 SACOL0589 rpoC B4, B8, B9, BB2, BB3, DD6, DD7 b
17 SACOL0758 fruK DD5 d
20 SACOL1689 relA2 BB8, D3 a
21 SACOL1710 valS C8 c
23 SACOL1717 hemC AA2 d
24 SACOL1745 pyk A5 d
25 SACOL2038 gcp CC1 c
27 SACOL2108 sua-5 DD1 c
28 SACOL2117 fbaA B10, BB5, BB6 d
29 SACOL2215 rpsM A2 c
a Mutation numbers as in Table 1.
FIG 2 Determination of PBP2A in membranes of H*R derivatives carrying single mutations. A group of H*R isolates carrying single mutations in a variety of
genes associated with high-level oxacillin resistance (Table 3) were analyzed by SDS-PAGE and by testing the relative amounts of PBP2A by Western blotting with
a monoclonal antibody prepared against PBP2A. Three isolates (A2, A5, and AA2) from family A, four isolates (B5, BB6, BB8, and BB9) from family B, and five
isolates from family D (D3, DD1, DD3, DD5, and DD6) were included in the analysis. Lanes A, B, and D show the SDS-PAGE profiles and the Western blot
analysis of PBP2A in these parental isolates. Lanes Am, Bm, and Dm contain parental samples in which the relative amounts of PBP2A were estimated in the
presence of mupirocin. The single mutations carried by the H*R derivatives of family A were as follows: rpsM in lane A2, pyk in lane A5, and hemC in lane AA2.
The single mutated genes analyzed in family B were prsA in lane B5, fbaA in lane BB6, relA2 in lane BB8, and guaA in lane BB9. The mutations analyzed in
members of family D were relA2 in lane D3, sua5 in lane DD1, hpt in lane DD3, fruK in lane DD5, and rpoC in lane DD6. The M lanes contain molecular size
markers (100, 70, 55, and 45 kDa).
Role of Stringent Stress in Drug Resistance
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DISCUSSION
Inspection of Table 1 through 3 and the figures indicates that a
large number and different kinds of mutations can profoundly
influence the phenotypic expression of oxacillin resistance in the
four heteroresistant MRSA strains. Determinants include genes in
cell division as well as genes associated with various aspects of
intermediary metabolism. Such a diversity of genetic determi-
nants is reminiscent of the large number of “auxiliary genes” (or
fem genes) identified earlier as determinants essential for the op-
timal expression of high and homogeneous resistance in MRSA
strains (34, 35). As a hypothesis to account for the polygenic na-
ture of this phenomenon, it was proposed that the expression of
antibiotic resistance involves a bacterial stress response (36).
This proposition, originally suggested to explain the multi-
genic nature of homogeneous oxacillin resistance, seems to also fit
the mechanism of heterogeneous resistance analyzed in this com-
munication. In a recent study, we described identification of the
critical role that the S. aureus relA gene plays in the phenotypic
expression of oxacillin resistance (20). RelA protein plays a central
role in the control of biosynthetic activities through its catalytic
product—ppGpp and pppGpp—that can interact with and regu-
late the ribosomal protein synthesis machinery.
The large number and functional diversity of the determinants
that influence heterogeneous expression of resistance as described
in this communication would fit the model in which a stress re-
sponse—specifically, the stringent stress—is the ultimate control-
ling factor of the phenotypic expression of oxacillin resistance in
MRSA (20, 21).
Figure 3 shows a modification of the relA model to indicate
how diverse genetic determinants identified in the present com-
munication could impact on the level of antibiotic resistance
through specific interactions with the relA-controlled RNA poly-
merase system. In a recent communication (21), we began to test
whether the physiological level of antibiotic resistance (i.e., the
oxacillin MIC value) is paralleled by the cellular amounts of the
mecA gene product PBP2A. In the model systems described in
reference 21, increase in the MIC value was accompanied by a
parallel increase in the cellular amounts of PBP2A, and increased
amounts of PBP2A were also detected in the H*R derivatives de-
scribed in this communication (Fig. 2).
If the stringent stress response is the central controlling ele-
ment of the level of oxacillin resistance in MRSA, then one would
expect that artificial triggering of the stress response would con-
vert heterogeneously resistant MRSA to highly and homoge-
neously resistant cultures. In an effort to test this, we repeated the
population analysis of the four heteroresistant “parental” strains
in the presence of sub-MICs of mupirocin, an agent capable of
inducing stringent stress. Figure 4 demonstrates that each one of
the four heteroresistant parental MRSA strains described in this
communication would exhibit high and homogeneous resistance
FIG 3 Model for the triggering of the stringent stress response by mutations identified in the highly resistant (H*R) isolates. A schematic model for the
postulated effect of H*R mutations on the relA-controlled stress response of S. aureus is shown. Functional categories of mutations are defined as in Table 2. HD,
hydrolase; SYN, synthetase; TGS, a domain named after three enzymes that contain it [threonyl-tRNA synthetase (ThrRS), GTPase, and guanosine-3=,5=-
bis(diphosphate) 3=-pyrophosphohydrolase (SpoT)]; ACT, the domain named after three proteins that carry it [aspartate kinase, chorismate mutase, and
prephenate dehydrogenase (TyrA)].
Dordel et al.
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if the phenotype was assayed in the presence of sub-MICs of mupi-
rocin added to the oxacillin-containing agar plates. Identical re-
sults were obtained when serine hydroxamate, an inhibitor of
seryl-tRNA synthetase, was used instead of mupirocin. These ob-
servations may open up so-far untested avenues for the design of
antibacterial agents that could influence resistance level of MRSA
through a novel type of intervention.
MATERIALS AND METHODS
Aliquots (1l) of the four heteroresistant “parental” cultures of UK13136
(parental strain of family A), ST63/458 (parental strain of family B), E2125
(parental strain of family C), and E4278 (parental strain of family D) were
inoculated into 5 ml of tryptic soy broth (TSB) and incubated at 37°C
overnight with agitation. Portions (1 ml) of the overnight cultures were
removed to prepare chromosomal DNAs representing the majority of
cells (poorly resistant cells) of these cultures. The overnight cultures were
diluted with TSB, and population analysis profiles (PAPs) were done on
tryptic soy agar (TSA) plates containing increasing concentrations of ox-
acillin (Fig. 1). CFU were counted after 48-h incubation of the plates at
37°C. Twenty medium-size colonies capable of growing on TSA plates
containing 100g/ml oxacillin were picked from the PAP plates of each of
the four “parental” MRSA. These colonies were named “H*R” for homo-
geneous and high-level oxacillin resistance. H*R colonies were recovered
from the plates with 1-l loops and dispersed into Eppendorf tubes con-
taining 200 l of TSB. Portions (1 l) from each Eppendorf tube were
streaked onto a TSA plate which was incubated at 37°C for 48 h. The H*R
isolates were next passaged three times onto fresh TSA plates, after which
the isolates were retested for resistance level by Etest and population anal-
ysis. A total of 42 H*R isolates with high-level and homogeneous oxacillin
resistance (oxacillin MIC of 400 g/ml) were inoculated into 5 ml of
TSB, incubated at 37°C with agitation overnight, and used to prepare H*R
DNAs. The 42 H*R isolates included 10 colonies of UK13136, 12 of UK63/
458, 10 of E2125, and 10 of E4278.
The antibiotic resistance profiles of the four heteroresistant strains
were also determined by including sub-MICs of mupirocin in the
antibiotic-containing plates used for population analysis (37, 38). Mupi-
rocin is a known inducer of the stringent stress response in bacteria.
Genome sequencing. Sequencing libraries were prepared according to
previously published methods (39–41). Samples were run on an Illumina
HiSeq 2000 sequencer operated according to the manufacturer’s instruc-
tions with 100 cycle paired-end runs. Data for the samples have been
deposited in the European Nucleotide Archive (see below).
Detection of variations between H*R isolates and the “parental”
strains. The sequence of chromosomal DNAs isolated from the H*R col-
onies was compared to the DNA sequence of the corresponding “paren-
tal” strain in order to identify in the H*R isolates mutated loci that may be
associated with the high-level oxacillin-resistant phenotype of these
clones. This was done using three different approaches to call only high-
confidence variants.
The first two approaches are based on de novo assemblers, which are
capable of detecting variants (single nucleotide polymorphisms [SNPs]),
insertions, and deletions while building the contigs. Both methods com-
pletely ignore reference genomes while calling variants between “paren-
tal” and H*R isolates. However, to make comparison between the meth-
ods easier, the results were mapped back to reference strain COL
(GenBank accession number CP000046).
SGA v0.9.19 (42) commands “preprocess” and “index” were run using
default settings. Variants were called using “graph-diff” with k-mer (k)
FIG 4 Conversion of the heterogeneous population analysis profiles of four MRSA strains to high and homogeneous resistance by induction of the stringent
stress response. Population analysis profiles (PAPs) of the four MRSA cultures (strains in Fig. 1A to D) (solid squares), PAPs of H*R derivatives (empty squares),
and PAPs determined on agar plates on which the antibiotic was supplemented by sub-MICs (0.03 g/ml) of mupirocin (solid circles). Asterisks indicate the
concentration of oxacillin (100 g/ml) at which the H*R colonies were picked.
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 61 and min-discovery-count (x) 10. Cortex v1.0.5.15 (43) was run
using the provided workflow pipeline using the joint variant discovery
with k-mers between 31 and 63 (43).
The third approach is based on mapping. Each “parental” isolate and
corresponding H*R isolates were mapped against strain COL using
SMALT v.0.7.4 (http://www.sanger.ac.uk/resources/software/smalt).
High-quality SNPs were called as described previously (44). Detection of
indels was carried out using GATK (45). The obtained variant call format
files (VCFs) were processed using an in-house script to remove variant
calls due to the use of the reference genome COL in order to find only
differences between the “parental” strain and H*R isolates. Variants
found by all three methods were finally checked manually in order to carry
on further analysis with high-quality variants.
Preparation of staphylococcal membrane proteins. Membrane frac-
tions were prepared from isolates belonging to families A, B, and D fol-
lowing the method described previously (21, 38) with slight modification.
S. aureus strains were grown at 37°C in 200 ml of TSB in the presence of
0.5 g/ml of oxacillin to induce transcription of the mecA gene. The
strains analyzed included three H*R isolates from family A (A2, A5, and
AA2), four H*R isolates from family B (B5, BB6, BB8, and BB9), and five
H*R isolates from family D (D3, DD1, DD3, DD5, and DD6). Each anal-
ysis included the SDS-PAGE profiles of the corresponding parental strain:
strain UK13136 for family A, strain ST63/458 for family B, and strain
E4278 for family D. The relative amounts of PBP2A were determined in
each of the isolates using Western blotting. The SDS-PAGE profiles and
relative amounts of PBP2A were also compared for each of the parental
strains with and without mupirocin (0.03 g/ml) added to the growth
medium. All cultures were harvested at an optical density at 620 nm
(OD620) of 0.5, washed, and resuspended in 3 ml of 20 mM Tris-HCl
(pH 7.6) containing 1 Halt protease inhibitor cocktail (Thermo Fisher
Scientific, Inc.), 10 mM MgCl2, 100 g/ml lysostaphin, 50 g/ml ly-
sozyme, 50 g/ml DNase I, and 50 g/ml RNase A. The cells were incu-
bated at 37°C for 30 min and disrupted by sonication with pulse of 40%
output for 5 min. The supernatants were transferred to fresh ultracentri-
fuge tubes after centrifugation at 7,000  g for 20 min. Membrane frac-
tions were collected by centrifugation at 100,000 g for 1 h. The collected
membranes were resuspended in 20 mM Tris-HCl (pH 7.6) and stored at
70°C. The concentration of total membrane proteins was determined by
the bicinchoninic acid (BCA) assay.
Western blotting. Western blotting with a monoclonal antibody pre-
pared against PBP2A was used to determine PBP2A in membrane prepa-
rations as described previously with a few modifications (21, 38). The
membrane proteins (50 g for families A and B and 100 g for family D)
were loaded on the polyacrylamide gel (8% or 10% resolving gel; 4%
stacking gel) for SDS-PAGE. The rabbit anti-PBP2A antibody was used as
the primary antibody with dilution of 1:15,000, and the secondary horse-
radish peroxidase (HRP)-conjugated anti-rabbit antibody (0.5 mg/ml;
PerkinElmer) was diluted to 1:10,000. ChromPure human IgG Fc frag-
ment (Millipore) was added to the blocking solution at a final concentra-
tion of 3 g/ml in order to prevent the antibodies from nonspecific bind-
ing. Pierce enhanced chemiluminescence (ECL) 2 (Thermo Fisher
Scientific, Inc.) substrate was used for visualization of PBP2A bands with
X-ray film exposure.
Nucleotide sequence accession numbers. Data for the genome se-
quencing samples have been deposited in the European Nucleotide Ar-
chive under the sample numbers ERS157365, ERS157381, ERS157396,
ERS157409, and ERS157425 to ERS157449.
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